ATC Group: A03AE01 Alosetron

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A03AE01 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Drugs for functional gastrointestinal disorders
3
DRUGS FOR FUNCTIONAL BOWEL DISORDERS
4
Drugs acting on serotonin receptors
5
A03AE01
Alosetron

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
1 mg

Active ingredients in A03AE01

Active Ingredient
Description

Alosetron is a potent and selective 5-HT3 receptor antagonist. 5-HT3 receptors are ligand-gated cation channels that are extensively distributed on enteric neurons in the human gastrointestinal tract, as well as other peripheral and central locations.